Amgen Joins National Cancer Institute, Other Companies On Lung-MAP Project

Monday, June 16, 2014 - 23:00 in Health & Medicine

Amgen announced that it will collaborate with the National Cancer Institute and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a clinical trial program that will use biomarker-driven research and genomic profiling to match squamous cell lung cancer patients to investigational treatments based on their individual cancer profiles. read more

Read the whole article on

More from

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net